Cargando…

Real-life patient experiences of TTNS in the treatment of overactive bladder syndrome

INTRODUCTION AND OBJECTIVES: Overactive bladder syndrome (OAB) is defined as urinary urgency, with or without urgent urinary incontinence; it is often associated with urinary frequency and nocturia, in the absence of any pathological or metabolic conditions that may cause or mimic OAB. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	te Dorsthorst, Manon, van Balken, Michael, Janssen, Dick, Heesakkers, John, Martens, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Advances in Urogynaecology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411642/ https://www.ncbi.nlm.nih.gov/pubmed/34484428 http://dx.doi.org/10.1177/17562872211041470

Ejemplares similares

Preoperative abdominal straining in uncomplicated stress urinary incontinence: is there a correlation with voiding dysfunction and de novo overactive bladder after mid-urethral sling procedures?
por: Iacovelli, Valerio, et al.
Publicado: (2021)

Patient‐tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms
por: te Dorsthorst, Manon, et al.
Publicado: (2022)

Current role of neuromodulation in bladder pain syndrome/interstitial cystitis
por: Padilla-Fernández, Bárbara, et al.
Publicado: (2022)

Imaging findings of vinyl dimethyl polydimethylsiloxane used as a paraurethral injectable for female stress urinary incontinence
por: de Vries, Allert M., et al.
Publicado: (2021)

Pentosan polysulfate in patients with bladder pain syndrome/interstitial cystitis with Hunner’s lesions or glomerulations: systematic review and meta-analysis
por: Grigoryan, Bagrat, et al.
Publicado: (2022)

Three-dimensional bladder ultrasonography with the BladderScan(®) overestimates post void residual one week after delivery
por: Salimans, Simone, et al.
Publicado: (2019)

Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder
por: Heesakkers, John, et al.
Publicado: (2022)

Does monthly self-management of vaginal ring pessaries reduce the rate of adverse events? A clinical audit
por: Moore, Kate H., et al.
Publicado: (2022)

Wound dehiscence prevalence and relationship with prosthetic material extrusion in women underwent anterior colpotomy
por: Balzarro, Matteo, et al.
Publicado: (2021)

Effect of polyfluoroalkyl chemicals on the occurrence of urge urinary incontinence: a population-based study
por: Cui, Shu, et al.
Publicado: (2021)

Could the vaginal wall sling still have a role after FDA’s warning? the functional outcomes at 20 years
por: Illiano, Ester, et al.
Publicado: (2022)

Robot-assisted sacro(hystero)colpopexy with anterior and posterior mesh placement: impact on lower bowel tract function and clinical outcomes at mid-term follow-up
por: Li Marzi, Vincenzo, et al.
Publicado: (2022)

Development of a prediction model in female pure or predominant urge urinary incontinence: a retrospective cohort study
por: van Doorn, Tess, et al.
Publicado: (2022)

Efficacy of magnetic stimulation for female stress urinary incontinence: a meta-analysis
por: Sun, Kai, et al.
Publicado: (2021)

Long‐term real‐life adherence of percutaneous tibial nerve stimulation in over 400 patients
por: te Dorsthorst, Manon J., et al.
Publicado: (2019)

Vaginal repair with mesh versus colporrhaphy for prolapse: a randomised controlled trial
por: Carey, M, et al.
Publicado: (2009)

Fractional CO(2) laser for treatment of stress urinary incontinence
por: Behnia-Willison, Fariba, et al.
Publicado: (2019)

Laparoscopic sacrocolpopexy (LSCP) using an ultra-lightweight polypropylene mesh()
por: Dwyer, Lucy, et al.
Publicado: (2019)

Study of the polymorphism rs3025058 of the MMP-3 gene and risk of pelvic organ prolapse in Brazilian women
por: Maeda, Paula M., et al.
Publicado: (2019)

The role of transforming growth factor-ß (TGF-ß1) in postmenopausal women with pelvic organ prolapse: An immunohistochemical study
por: Carlin, Greta Lisa, et al.
Publicado: (2020)

Patient’s characteristics and incidence of fecal incontinence after primary repair of Obstetric Anal Sphincter Injuries (OASIS) at three Indonesian tertiary hospitals in 2014–2016
por: Djusad, Suskhan, et al.
Publicado: (2020)

Influence of current state of executive function and working memory on adherence to antimuscarinic therapy in older women with OAB
por: Kosilov, Kirill, et al.
Publicado: (2019)

Feasibility study for the value of pelvic floor distension in predicting mode of birth for women undergoing Vaginal Birth After Caesarean
por: Toozs-Hobson, Philip, et al.
Publicado: (2021)

Maternal risk factors of urinary incontinence during pregnancy and postpartum: A prospective cohort study
por: Rajavuori, Anna, et al.
Publicado: (2021)

Histopathological features in advanced abdominal pregnancies co-infected with SARS-CoV-2 and HIV-1 infections: A case evaluation
por: Ramphal, S., et al.
Publicado: (2022)

Clinical utility of neurostimulation devices in the treatment of overactive bladder: current perspectives
por: Janssen, Dick AW, et al.
Publicado: (2017)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023)

Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data
por: Andretta, Elena, et al.
Publicado: (2022)

Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial
por: Ghijselings, Lynn, et al.
Publicado: (2021)

Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome
por: de Wall, Liesbeth L, et al.
Publicado: (2017)

Overactive Bladder: Pathophysiology, Diagnostics, and Therapies
por: Heesakkers, John P. F. A., et al.
Publicado: (2011)

Solifenacin in Multiple Sclerosis Patients with Overactive Bladder: A Prospective Study
por: van Rey, Farida, et al.
Publicado: (2011)

Study protocol of a multicentre double-blind RCT, comparing a traditional RCT with an aggregated N-of-1 trial: GAG therapy Efficacy Trial Solution for Bladder pain syndrome/Interstitial cystitis (GETSBI study)
por: van Ginkel, Charlotte, et al.
Publicado: (2023)

Dealing with complex overactive bladder syndrome patient profiles with focus on fesoterodine: in or out of the EAU guidelines?
por: Heesakkers, John, et al.
Publicado: (2017)

Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome
por: Mu, Hsueh-Yu, et al.
Publicado: (2023)

Telemedicine in Overactive Bladder Syndrome
por: Jericevic, Dora, et al.
Publicado: (2023)

The Burden of Urinary Tract Infections on Quality of Life and Healthcare in Patients with Interstitial Cystitis
por: Baars, Cléo, et al.
Publicado: (2023)

Mirabegron, alone and in combination, in the treatment of overactive bladder: real-world evidence and experience
por: Allison, Sara J., et al.
Publicado: (2018)

Vaginal laser for overactive bladder syndrome
por: Charalampous, Ioannis, et al.
Publicado: (2020)

Clustering of patients with overactive bladder syndrome
por: Gross, James, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q37q13dojnq4jnrgartft6q17i